Americas (WHO region) vs Sweden: Estimated antiretroviral therapy coverage among people living with HIV
Americas (WHO region)
71.0%
in 2025
Sweden
95.0%
in 2024
Americas (WHO region) rank
4th
Sweden rank
5th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Americas (WHO region)
- Sweden
How they compare
Sweden currently reports 95.0% against 71.0% in Americas (WHO region), a difference of 24.0%.
That makes Sweden's figure about 1.3 times Americas (WHO region)'s.
Across all 25 years both countries report, Sweden has been ahead every year.
Americas (WHO region) ranks 4th and Sweden ranks 5th of 13 groups.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Americas (WHO region) | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 25.9% | 48.8% | 22.9% | Sweden |
| 2010s | 51.4% | 90.8% | 39.4% | Sweden |
| 2020s | 67.0% | 95.8% | 28.8% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Americas (WHO region) or Sweden?
- Sweden, at 95.0% against 71.0% in Americas (WHO region) as of 2024.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Americas (WHO region) and Sweden?
- 24.0%, with Sweden ahead.
- How many years of comparable data are there for Americas (WHO region) and Sweden?
- 25 years are reported by both, from 2000 to 2024.
- How do Americas (WHO region) and Sweden rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Americas (WHO region) ranks 4th and Sweden ranks 5th of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.